Breast cancer cells that reside in the bone ECM induce osteoclast formation by releasing tumor necrosis factor-α (TNF-α), parathyroid hormone-related peptide (PTH-rP), prostaglandin E2 (PGE2), interleukins, and leukemia inhibitory factor (LIF). This evidence concerns the gene TNF and breast cancer.